Streamlining Clinical Development
-
Read MoreHow RWE can help Biotechs optimize the value of their asset
-
Read MoreNavigating Covid-19 to Support Next-Gen Patient Focused Treatments
-
Read MoreParexel Biotech Brochure
-
Read MoreCOVID19 The Great Decentralized Clinical Trials Accelerator
Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.
-
Read MoreRare disease clinical trial patient identification and recruitment
-
2:56Watch VideoGenomics & biomarkers: Answers in the blood
Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi
-
Read More
Getting real-world data into clinical research
Learn more about how to address operational challenges that come with harnessing RWD.
-
Learn MoreTop 10 Myths About Working with the FDA for an Oncology Drug Approval
Amy McKee, Vice President Regulatory Consulting Services, addresses some of the most common misconceptions about working with the FDA.
-
2:41Watch VideoEndpoints That Matter
Parexel’s Andreas Reiff, VP, Global TA Head, Inflammation/Immunology talks with Julie Stover, Senior Director, Solution Consulting, also from Parexel, about her journey being diagnosed with Ankylosing
-
Learn MoreThe future is now: Decentralized clinical trials during the pandemic and beyond
Enabling patients to participate in clinic trials from home is both important to maintain patient safety and data quality in ongoing trials and critical for many new trials as we plan for COVID-19.
-
Watch WebinarOn-demand webinar: Value of real-world evidence and synthetic control arms
Learn about the benefits that real-world evidence (RWE) can bring to small & mid-size biotech companies.
-
Read More
Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company
For biotech companies, precision medicine holds tremendous promise for innovation – for newly designed drugs, new technologies for drug delivery, and engineered cell or gene therapies.
-
Learn MoreCOVID-19 and the impact on pediatric clinical trials
The COVID-19 global pandemic has had a significant impact on the conduct of pediatric and adult clinical drug trials. Many trials have halted enrollment, and there are multiple challenges with...
-
Learn MoreCOVID-19 and the effect on cellular therapy trials
In clinical trials for cellular and gene therapies, the COVID-19 pandemic has created enormous complexities. Parexel experts Matthew M. Cooney, MD and Roberta L. Steere offer a brief overview.
-
Learn MoreExpediting Biotech Product Development During the COVID-19 Pandemic using Modular Validation Approaches
For over three months the world has been battling COVID-19. COVID-19 is unforgiving and has the ability to overwhelm even the strongest health system or regulatory regime. Even though the...
-
Read MoreIndustry Perspectives on Decentralized Clinical Trials
-
Read More
Successful wearable device selection within the clinical trials industry
Learn more about key considerations when selecting the right wearable device for your clinical trial.
-
Learn MoreThe Parexel Podcast | Episode 6: The opportunity for biotechs in precision medicine
Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more...
-
Learn MorePodcast: Opportunities for biotechs in precision medicine, driving value and bringing important new therapies to patients
Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss how biotech companies can incorporate precision medicine into their development plans.
-
Learn MoreDrug development innovations that work: Precision medicine
Learn more about new regulatory frameworks for precision medicine and how best to demonstrate results for regulatory bodies.
-
Loading More...
